Rosiglitazone [rosiglitazon]
- Terms
-
Avandia
rosiglitazon maleát
-
5-((4-(2-Methyl-2-(pyridinylamino)ethoxy)phenyl)methyl)-2,4-thiazolidinedione-2-butenedioate
Avandia
BRL 49653
BRL-49653
BRL49653
Rosiglitazone Maleate
A thiazolidinedione that functions as a selective agonist for PPAR GAMMA. It improves INSULIN SENSITIVITY in adipose tissue, skeletal muscle, and the liver of patients with TYPE 2 DIABETES MELLITUS.
- DUI
- D000077154 MeSH Browser
- CUI
- M0237199
- CAS
- 2,4-Thiazolidinedione, 5-((4-(2-(methyl-2-pyridinylamino)ethoxy)phenyl)methyl)-
- History note
- 2019 (1994)
- Public note
- 2019; ROSIGLITAZONE was indexed under THIAZOLIDINEDIONES 2004-2018, and under THIAZOLES 1994-2003
Allowable subheadings
- AD
- administration & dosage 1
- AE
- adverse effects 2
- AG
- agonists
- AA
- analogs & derivatives
- AN
- analysis
- AI
- antagonists & inhibitors
- BL
- blood
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry
- CL
- classification
- EC
- economics
- HI
- history
- IM
- immunology
- IP
- isolation & purification
- ME
- metabolism 1
- PK
- pharmacokinetics
- PD
- pharmacology
- PO
- poisoning
- RE
- radiation effects
- ST
- standards
- SD
- supply & distribution
- TU
- therapeutic use 2
- TO
- toxicity
- UR
- urine